Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Positive”

199 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 199 results

Testing effectiveness (Phase 2)Ended earlyNCT06595563
What this trial is testing

HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute 87
Very early researchLooking for participantsNCT07830771
What this trial is testing

Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
University of Pennsylvania 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692103
What this trial is testing

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Who this might be right for
Estrogen Receptor PositivePrimary or Recurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 2
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Not applicableStudy completedNCT00833625
What this trial is testing

FDG-PET-CT and Biomarkers in Esophageal Cancer

Who this might be right for
Gastrointestinal DiseaseEsophageal Cancer
M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT04271579
What this trial is testing

Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)

Who this might be right for
Prostate Cancer
Martini-Klinik am UKE GmbH 397
Not applicableLooking for participantsNCT07089550
What this trial is testing

PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)

Who this might be right for
PSMA Positive Tumors or Tumor TissuesProstate Cancer Metastatic
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,300
Testing effectiveness (Phase 2)Study completedNCT00425113
What this trial is testing

Metronidazole for Pulmonary Tuberculosis (South Korea)

Who this might be right for
TuberculosisMulti-Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Study completedNCT03581305
What this trial is testing

PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects

Who this might be right for
DepressionHIV InfectionsHIV-Associated Cognitive Motor Complex
National Institutes of Health Clinical Center (CC) 46
Testing effectiveness (Phase 2)Study completedNCT04150731
What this trial is testing

16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer

Who this might be right for
Breast Cancer
University of Aarhus 8
Very early researchEnded earlyNCT03001349
What this trial is testing

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Who this might be right for
MeningiomaMetastatic Well Differentiated Neuroendocrine NeoplasmMultiple Endocrine Neoplasia Type 1+3 more
M.D. Anderson Cancer Center 4
Not applicableStudy completedNCT04324983
What this trial is testing

Identification of Predictive Biomarkers

Who this might be right for
Prostate Cancer Recurrent
Martini-Klinik am UKE GmbH 150
Testing effectiveness (Phase 2)Study completedNCT05653856
What this trial is testing

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate (Disorder)
Curium US LLC 26
Testing effectiveness (Phase 2)Study completedNCT02423122
What this trial is testing

A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
EIP Pharma Inc 16
Testing effectiveness (Phase 2)UnknownNCT00907036
What this trial is testing

Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 49
Testing effectiveness (Phase 2)Looking for participantsNCT04824014
What this trial is testing

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

Who this might be right for
ER+ Breast Cancer
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 150
Not applicableLooking for participantsNCT07760012
What this trial is testing

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

Who this might be right for
Melanoma (Skin Cancer)Hepatocellular CarcinomaLung Cancer+3 more
Peking University Third Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT05397171
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Who this might be right for
Urinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung
AstraZeneca 17
Very early researchEnrolling By InvitationNCT07023861
What this trial is testing

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Who this might be right for
Breast CancerGastric Cancer (GC)Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University 20
Not applicableActive Not RecruitingNCT01996046
What this trial is testing

FDG PET/CT in Breast Cancer Bone Mets

Who this might be right for
Estrogen Receptor Positive Breast CancerBone Metastases
University of Pennsylvania 75
Next Page